Generex Biotechnology Corporation

(NASDAQ:GNBT)
  Jul 31, 2008 Apr 30, 2008 Jan 31, 2008 Oct 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 21,026 21,026 21,026 21,026
Cash At End Of Period 17,238 15,342 2,520 1,674
Net Change In Cash And Cash Equivalents -3,789 -5,684 -18,506 -19,352
Effect Of Exchange Rate Changes -51 -58 -42 -1
Net Income Or Loss -36,229 -23,903 -13,729 -7,222
Cash From Operating Activities
Depreciation Expenses 1,085 847 600 307
Amortization Expenses 3,689 460
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables -31 -39 -51 16
Increase Or Decrease In Inventories -729 -248 -131
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables -1,346 80 16 48
Increase Or Decrease In Other Current Liabilities 54 2,663 -923 159
Increase Or Decrease In Other Working Capital 855 71 69 13
Other Non Cash Items
Net Cash From Continuing Operations 3,614 2,621 2,057 1,171
Net Cash From Discontinued Operations -28,309 -17,931 -12,208 -5,639
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -290 -55 -121 -83
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments -23,148 -24,018 -18,001 -17,755
Other Investing Changes Net 51 -281 31 -34
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 4,921 -7,370 -6,261 -13,690
Cash From Financing Activities
Issuance Of Debt 392 392 49
Issuance Of Capital Stock -89 -67 -44 -22
Repayment Of Debt -378 -378
Repurchase Of Capital Stock
Payment Of Cash Dividends -723 -723
Net Other Financing Charges -723 -723
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 19,651 19,674 5 -22